| 发明名称 |
Muscarinic agonists. |
| 摘要 |
Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment. |
| 申请公布号 |
ZA200208504(B) |
申请公布日期 |
2004.01.22 |
| 申请号 |
ZA20020008504 |
申请日期 |
2002.10.21 |
| 申请人 |
ACADIA PHARMACEUTICALS, INC. |
发明人 |
CARL-MAGNUS A. ANDERSSON;NIELS SKJAERBAEK;ALLAN K. ULDAM;BO LENNART M. FRIBERG;TRACY SPALDING |
| 分类号 |
C07D249/18;A61K31/4439;A61K31/52;A61P25/02;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P27/06;C07C271/28;C07D261/20;C07D333/54;C07D401/06;C07D405/06;C07D407/04;C07D409/04;C07D409/06;C07D413/06;C07D413/12;C07D417/06;C07D471/04;C07D473/00;C07D487/04;C07F7/22 |
主分类号 |
C07D249/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
